View Press Releases
-
ZeOmega Partners With Datycs to Digitize Faxed Documents and Automate Healthcare Data Workflows
This collaboration allows payers to make processes such as prior authorization more efficient; especially critical given the new requirements for faster turnaround times. Digitizing faxed documents and applying technologies such as AI and NLP to mine data cuts back on manual steps, reducing administrative burden and costs.
Jan 29, 2024
-
Currax Pharmaceuticals Announces First Patient Screened into the INFORMUS Cardiovascular Outcomes Trial
Currax Pharmaceuticals announces the first patient screened and accepted into the CONTRAVE® INFORMUS Cardiovascular Outcomes Trial (NB-CVOT3).
Jan 29, 2024
-
Lactocore Group leverages milk peptides to combat inflammaging
Body-wide inflammation is linked to many chronic diseases, affecting health and longevity. Recent data indicates that milk protein hydrolysate is a promising source of novel bioactive peptides. These peptides have potential application in correcting inflammaging and age-associated metabolic disorders
Jan 30, 2024
-
Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery
Vector Laboratories and Navinci Diagnostics announced that they have signed an agreement to develop cutting-edge biomarker discovery tools, allowing detection of specific protein glycosylation in tissue samples.
Jan 29, 2024
-
Creative Biogene Debuts Revolutionary Single Cell CRISPR Library Screening Services
-
Qlucore Diagnostics for Pediatric leukemia takes a Significant step closer to CE marking
Qlucore, a leader in software development for precision cancer diagnostics, has taken the final major step in the process towards a CE-marked medical device for in-vitro diagnostics by submitting the technical documentation to a Notified Body. The CE marked product, Qlucore Diagnostics, is due to be launched in February 2025.
Jan 30, 2024
-
Transformative Impact of AR and VR Technologies in Healthcare Amidst the COVID-19 Pandemic
The COVID-19 pandemic has acted as a catalyst for the integration of AR and VR technologies in the healthcare industry. From training healthcare professionals to addressing staff shortages, educating patients, and facilitating treatment and rehabilitation, these immersive technologies have proven their worth in navigating the complexities of the ongoing global health crisis. As the world continues to grapple with the challenges posed by the pandemic, the role of AR and VR in healthcare is likely to evolve and expand, ushering in a new era of innovation and resilience in the face of health emergencies.
Jan 29, 2024
-
Creative Enzymes Revolutionizes the Field with Advanced Industrial Enzyme Production Service
-
Creative Enzymes Introduces Pyranose Oxidase from Microorganism for Enhanced Industrial Applicability
-
Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release
Drug discovery specialists Cresset have just released a new version of their drug discovery platform Flare.
Jan 28, 2024
-
Creative Proteomics Offers Advanced Steroids Analysis Service for Medical Industry
-
CD BioSciences Releases Analysis of Marine Organisms to Drive Marine Bioresearch Forward
CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.
Jan 28, 2024
-
Creative Proteomics Bolsters Its Position in Biomarker Discovery with N-Glycan and O-Glycan Profiling Services
-
Creative Proteomics Amplifies Its Services with High-precision Amino Acid Analysis
-
Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston
Recognizing the critical role of artificial intelligence in accelerating drug discovery, Bio-IT World Conference & Expo is offering expanded content on this pivotal technology at its 23rd annual event.
Jan 24, 2024
-
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
Jan 24, 2024
-
CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy
-
Alfa Chemistry Announces Ability to Supply Recombinant Human Collagens
-
Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents
-
MedPharm, Ltd. Expands Senior Leadership Team with New Senior Director of Sales & Marketing
MedPharm, Ltd. is announcing the addition of Daniel Morland to its Senior Leadership Team as Senior Director of Sales & Marketing. Dan has more than 15 years of experience in the pharmaceutical industry and will be based out of the company's Headquarters in Guildford, UK. He will directly oversee MedPharm's global commercial efforts.
Jan 25, 2024